• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

披露科学研究与出版中人工智能的使用情况:何时披露应为强制、自愿或无需披露?

Disclosing artificial intelligence use in scientific research and publication: When should disclosure be mandatory, optional, or unnecessary?

作者信息

Resnik David B, Hosseini Mohammad

机构信息

National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA.

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Account Res. 2025 Mar 24:1-13. doi: 10.1080/08989621.2025.2481949.

DOI:10.1080/08989621.2025.2481949
PMID:40126451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12353913/
Abstract

Currently there is a broad consensus among scholars that artificial intelligence (AI) tools can be used in research and publication, and that their use should be disclosed. Publishers and influential organizations, like the International Committee of Medical Journal Editors, have developed different and sometimes contradictory disclosure policies. We review some of these policies, examine the ethical reasons for disclosing AI use in research, and develop a framework for disclosure. We distinguish between mandatory, optional, and unnecessary disclosure of AI use, arguing that disclosure should be mandatory only when AI use is intentional and substantial. AI use is intentional when it is directly employed with a specific goal or purpose in mind. AI use is substantial when it 1) produces evidence, analysis, or discussion that supports or elaborates on the conclusions/findings of a study; or 2) directly affects the content of the research/publication. To support the application of our framework, we state three criteria for identifying substantial AI uses in research: a) using AI to make decisions that directly affect research results; b) using AI to generate content, data or images; and c) using AI to analyze content, data or images. Disclosure should be mandatory when AI use meets one of these criteria.

摘要

目前,学者们已达成广泛共识,即人工智能(AI)工具可用于研究和出版,且应披露其使用情况。出版商和有影响力的组织,如国际医学期刊编辑委员会,制定了不同且有时相互矛盾的披露政策。我们回顾其中一些政策,审视在研究中披露人工智能使用情况的伦理原因,并制定一个披露框架。我们区分了人工智能使用的强制披露、自愿披露和非必要披露,认为只有当人工智能的使用是有意且实质性的时,才应进行强制披露。当人工智能的使用是出于特定目标或目的而直接进行时,即为有意使用。当人工智能的使用:1)产生支持或阐述研究结论/结果的证据、分析或讨论;或2)直接影响研究/出版物的内容时,即为实质性使用。为支持我们框架的应用,我们阐述了识别研究中人工智能实质性使用的三个标准:a)使用人工智能做出直接影响研究结果的决策;b)使用人工智能生成内容、数据或图像;c)使用人工智能分析内容、数据或图像。当人工智能的使用符合这些标准之一时,就应进行强制披露。

相似文献

1
Disclosing artificial intelligence use in scientific research and publication: When should disclosure be mandatory, optional, or unnecessary?披露科学研究与出版中人工智能的使用情况:何时披露应为强制、自愿或无需披露?
Account Res. 2025 Mar 24:1-13. doi: 10.1080/08989621.2025.2481949.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Patient Restraint and Seclusion患者约束与隔离
4
"I Wish This Tool Was Available to Me Sooner": Piloting a Workplace Autism Disclosure Decision-Aid Tool for Autistic Youth and Young Adults.“真希望这个工具能早点提供给我”:为自闭症青少年和青年试行职场自闭症披露决策辅助工具
Autism Adulthood. 2024 Sep 16;6(3):331-344. doi: 10.1089/aut.2023.0054. eCollection 2024 Sep.
5
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Generative AI/LLMs for Plain Language Medical Information for Patients, Caregivers and General Public: Opportunities, Risks and Ethics.用于为患者、护理人员和普通公众提供通俗易懂的医学信息的生成式人工智能/大型语言模型:机遇、风险与伦理
Patient Prefer Adherence. 2025 Jul 31;19:2227-2249. doi: 10.2147/PPA.S527922. eCollection 2025.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.

引用本文的文献

1
Artificial intelligence policies in bioethics and health humanities: a comparative analysis of publishers and journals.生物伦理学与健康人文学科中的人工智能政策:出版商与期刊的比较分析
BMC Med Ethics. 2025 Jul 3;26(1):79. doi: 10.1186/s12910-025-01239-9.
2
Defining the Boundaries of AI Use in Scientific Writing: A Comparative Review of Editorial Policies.界定科学写作中人工智能使用的界限:编辑政策的比较综述
J Korean Med Sci. 2025 Jun 16;40(23):e187. doi: 10.3346/jkms.2025.40.e187.

本文引用的文献

1
The ethics of using artificial intelligence in scientific research: new guidance needed for a new tool.科学研究中使用人工智能的伦理问题:新工具需要新指南。
AI Ethics. 2025 Apr;5(2):1499-1521. doi: 10.1007/s43681-024-00493-8. Epub 2024 May 27.
2
Open Science at the generative AI turn: An exploratory analysis of challenges and opportunities.生成式人工智能时代的开放科学:挑战与机遇的探索性分析。
Quant Sci Stud. 2025;6:22-45. doi: 10.1162/qss_a_00337. Epub 2025 Jan 27.
3
The ethics of disclosing the use of artificial intelligence tools in writing scholarly manuscripts.在撰写学术手稿时披露使用人工智能工具的伦理问题。
Res Ethics. 2023 Oct;19(4):449-465. doi: 10.1177/17470161231180449. Epub 2023 Jun 15.
4
ChatGPT isn't an author, but a contribution taxonomy is needed.ChatGPT不是作者,但需要一个贡献分类法。
Account Res. 2024 Sep 18:1-6. doi: 10.1080/08989621.2024.2405039.
5
How to optimize the systematic review process using AI tools.如何使用人工智能工具优化系统评价过程。
JCPP Adv. 2024 Apr 23;4(2):e12234. doi: 10.1002/jcv2.12234. eCollection 2024 Jun.
6
Artificial Intelligence in Genetics.遗传学中的人工智能
Cureus. 2024 Jan 10;16(1):e52035. doi: 10.7759/cureus.52035. eCollection 2024 Jan.
7
Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications.聊天机器人、生成式人工智能与学术论文:世界医学编辑学会关于聊天机器人和生成式人工智能与学术出版相关的建议。
Colomb Med (Cali). 2023 Sep 30;54(3):e1015868. doi: 10.25100/cm.v54i3.5868. eCollection 2023 Jul-Sep.
8
Is AI leading to a reproducibility crisis in science?人工智能正在引发科学领域的可重复性危机吗?
Nature. 2023 Dec;624(7990):22-25. doi: 10.1038/d41586-023-03817-6.
9
Editors' Statement on the Responsible Use of Generative AI Technologies in Scholarly Journal Publishing.编辑关于在学术期刊出版中负责任地使用生成式人工智能技术的声明。
Hastings Cent Rep. 2023 Sep;53(5):3-6. doi: 10.1002/hast.1507. Epub 2023 Oct 1.
10
Chatbots, ChatGPT, and Scholarly Manuscripts: WAME Recommendations on ChatGPT and Chatbots in relation to scholarly publications.聊天机器人、ChatGPT与学术手稿:世界医学编辑协会关于ChatGPT和聊天机器人在学术出版方面的建议
Natl Med J India. 2023 Jan-Feb;36(1):1-4. doi: 10.25259/NMJI_365_23.